MedTrace Logo

Identification of Gulf War Illness (GWI) Biomarkers

NCT03082638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2025-03-17

No results posted yet for this study

Summary

The scientists working on this study want to use blood samples to identify components in blood, such as protein, lipids and their breakdown products to determine if they can be used for diagnosing Gulf War Illness (GWI). An additional goal is to examine the relationship of changes in these markers with the exposures and symptoms associated with GWI.

The Scientists will also prepare RNA and DNA from the blood samples for genetic analyses of certain proteins known to increase the risk for GWI. This information will be one of the factors included in the analysis of results from the protein studies.

Conditions

  • Gulf War Illness

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Roskamp Institute Inc.

    lead OTHER

Principal Investigators

  • Laila Abdullah, PhD · The Roskamp Institute, Inc

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-18
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03082638 on ClinicalTrials.gov